Gizmodo

A popular class of weight loss drugs may offer more lasting success than assumed, new data from Epic Research suggests. The study of medical records found that a slight majority of people who took GLP-1 drugs like semaglutide either maintained or improved their weight loss in the year after they stopped using the…

Read more...

Tech Insider
Renee Rayburg, vice president of specialty clinical consulting at Pharmaceutical Strategies Group
Renee Rayburg, vice president of specialty clinical consulting at Pharmaceutical Strategies Group
Gizmodo

If you told a person on the street in the 1970s that humans would have no base on the Moon by the year 2000, they’d probably laugh in your face. Well, it’s 2023 and we still lack even the barest of lunar infrastructure. But this week, Alenia Space and the Italian Space Agency sketched out their plans for a sustainable…

Read more...

Gizmodo

A study out this week suggests that semaglutide—the active ingredient in popular obesity drug Wegovy—might be able to help people struggling with alcohol use disorder, too. In a small sample of cases, researchers found evidence that people who took semaglutide for weight loss also experienced a significant reduction…

Read more...

Tech Insider
A poultice with the anti-diabetic medication Ozempic is pictured in a pharmacy
Ozempic is a diabetic medication.